Prathyusha Duraibabu is SVP, CHIEF FINANCIAL OFFICER of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 778,145 shares of SGMO, which is worth approximately $381,291. The most recent transaction as insider was on Mar 25, 2022, when has been sold 345 shares (Common Stock) at a price of $5.75 per share, resulting in proceeds of $1,984. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 778K
12.48% 3M change
6.31% 12M change
Total Value Held $381,291

Prathyusha Duraibabu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2022
SELL
Payment of exercise price or tax liability
$1,984 $5.75 p/Share
345 Reduced 0.39%
87,434 Common Stock
Feb 25 2022
SELL
Payment of exercise price or tax liability
$20,497 $5.9 p/Share
3,474 Reduced 6.91%
46,779 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
41,000 Added 31.84%
87,779 Common Stock
Jun 11 2021
BUY
Grant, award, or other acquisition
-
7,500 Added 13.08%
49,827 Common Stock
Apr 25 2021
SELL
Payment of exercise price or tax liability
$7,752 $11.71 p/Share
662 Reduced 1.62%
40,128 Common Stock
Mar 25 2021
SELL
Payment of exercise price or tax liability
$4,233 $12.27 p/Share
345 Reduced 0.84%
40,790 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$20,847 $11.19 p/Share
1,863 Reduced 6.37%
27,385 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
13,750 Added 25.05%
41,135 Common Stock

Also insider at

ORGO
Organogenesis Holdings Inc. Healthcare
PD

Prathyusha Duraibabu

SVP, CHIEF FINANCIAL OFFICER
Canton, MA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO